1. Home
  2. PBMWW vs VRNT Comparison

PBMWW vs VRNT Comparison

Compare PBMWW & VRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBMWW
  • VRNT
  • Stock Information
  • Founded
  • PBMWW N/A
  • VRNT 1994
  • Country
  • PBMWW Canada
  • VRNT United States
  • Employees
  • PBMWW 10
  • VRNT N/A
  • Industry
  • PBMWW
  • VRNT EDP Services
  • Sector
  • PBMWW
  • VRNT Technology
  • Exchange
  • PBMWW Nasdaq
  • VRNT Nasdaq
  • Market Cap
  • PBMWW N/A
  • VRNT N/A
  • IPO Year
  • PBMWW N/A
  • VRNT N/A
  • Fundamental
  • Price
  • PBMWW $0.01
  • VRNT $23.48
  • Analyst Decision
  • PBMWW
  • VRNT Buy
  • Analyst Count
  • PBMWW 0
  • VRNT 8
  • Target Price
  • PBMWW N/A
  • VRNT $35.43
  • AVG Volume (30 Days)
  • PBMWW N/A
  • VRNT 664.0K
  • Earning Date
  • PBMWW N/A
  • VRNT 12-04-2024
  • Dividend Yield
  • PBMWW N/A
  • VRNT N/A
  • EPS Growth
  • PBMWW N/A
  • VRNT N/A
  • EPS
  • PBMWW N/A
  • VRNT 0.67
  • Revenue
  • PBMWW N/A
  • VRNT $915,103,000.00
  • Revenue This Year
  • PBMWW N/A
  • VRNT $4.53
  • Revenue Next Year
  • PBMWW N/A
  • VRNT $4.42
  • P/E Ratio
  • PBMWW N/A
  • VRNT $35.25
  • Revenue Growth
  • PBMWW N/A
  • VRNT 3.03
  • 52 Week Low
  • PBMWW N/A
  • VRNT $21.28
  • 52 Week High
  • PBMWW N/A
  • VRNT $38.17
  • Technical
  • Relative Strength Index (RSI)
  • PBMWW N/A
  • VRNT 48.13
  • Support Level
  • PBMWW N/A
  • VRNT $24.07
  • Resistance Level
  • PBMWW N/A
  • VRNT $26.13
  • Average True Range (ATR)
  • PBMWW 0.00
  • VRNT 0.80
  • MACD
  • PBMWW 0.00
  • VRNT 0.36
  • Stochastic Oscillator
  • PBMWW 0.00
  • VRNT 45.36

About PBMWW Psyence Biomedical Ltd. Warrant

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: